GeneData launches new bioinformatics solution for infectious disease research
Swiss bioinformatics company GeneData, a developer of innovative computational solutions for genomics research, has launched PathoLead.
Swiss bioinformatics company GeneData, a developer of innovative computational solutions for genomics research, has launched PathoLead.
Claimed to be the first solution in the bioinformatics industry designed specifically for genomics-based anti-infectives research, it integrates genome, expression and phenotype data.
PathoLead is designed as a computational platform for the identification of targets and development of target-based and cell-based assays. Tools to identify genetic regulatory elements that govern a pathogen's antibiotics stress response facilitate the design of pathway-specific reporter assays suitable for high-throughput screening, the company says.
Furthermore, it enables the automated mechanism-of-action characterisation of novel small-molecule inhibitors based on signature mRNA profiles. The integrated inhibitor database supports the systematic biological characterisation and storage of proprietary drug development candidates and their respective target classes. It enables the concurrent analysis of hundreds of genomes and all major bacterial, fungal and viral pathogens.